Sherlock Biosciences was founded on the belief that we can vastly improve human health and industrial testing worldwide. Diagnostic tests developed with our Engineering Biology platforms will help us deliver results faster, accurately and more affordably. We envision a world where Sherlock’s products will enable users to make more effective decisions in any environment, including hospitals, industrial settings, low-resource settings, or at home. Our goal is to address significant unmet needs in infectious disease, oncology, agriculture, and other areas to transform diagnostic testing and global public health.
SHERLOCK is an evolution of CRISPR technology, which others use to make precise edits in genetic code. SHERLOCK can detect the unique genetic fingerprints of virtually any DNA or RNA sequence in any organism or pathogen. Developed by our founders and licensed exclusively from the Broad Institute, SHERLOCK is a method for single molecule detection of nucleic acid targets and stands for Specific High Sensitivity Enzymatic Report…
